Tevogen Bio Holdings (TVGN) Notes Payables (2023 - 2026)

Tevogen Bio Holdings has reported Notes Payables for 4 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables changed 0.0% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (changed 0.0% YoY), and the FY2025 full-year result was $1.7 million, changed 0.0% from the prior year.
• Notes Payables for Q1 2026 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
• The five-year high for Notes Payables was $80.7 million in Q4 2023, with the low at $625694.0 in Q2 2023.
• Historically, Notes Payables has averaged $8.1 million across 4 years, with a median of $1.7 million in 2024.
• The largest YoY upside for Notes Payables was 163.87% in 2024 against a maximum downside of 97.95% in 2024.
• Tevogen Bio Holdings' Notes Payables stood at $80.7 million in 2023, then tumbled by 97.95% to $1.7 million in 2024, then changed by 0.0% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• The last three Notes Payables figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.